FibroGen Inc (FGEN) – Company Profile and SWOT Analysis

FibroGen Inc (FGEN) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

FibroGen Inc (FibroGen) is a biopharmaceutical company primarily engaged in the development and commercialization of novel therapeutics for cancer biology and anemia. The company's main activities involve conducting clinical trials, advancing research, and in-licensing new product candidates. FibroGen's major products include Pamrevlumab, a first-in-class antibody targeting connective tissue growth factor (CTGF), and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor (HIF) prolyl hydroxylase. The company's products are primarily used in the treatment of life-threatening conditions such as metastatic pancreatic cancer, locally advanced pancreatic cancer (LAPC), and anemia associated with chronic kidney diseases. The company collaborates with partners like AstraZeneca and Fortis Therapeutics for the development and distribution of its products. FibroGen operates globally, with a significant presence in China, Europe, Japan, and other countries. FibroGen is headquartered in San Francisco, California, USA.

Scope

• Detailed information on FibroGen Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting FibroGen Inc in the form of a SWOT analysis

• An in-depth view of the business model of FibroGen Inc including a breakdown and examination of key business segments

• News about FibroGen Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess FibroGen Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on FibroGen Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Celgene Corp

Acceleron Pharma Inc

Glycomantra Inc

Boehringer Ingelheim International GmbH

Akebia Therapeutics Inc

Kyowa Kirin Co Ltd

Vifor Pharma Management Ltd

Bayer AG

Amgen Inc

3SBio Inc

Table of Contents